Evidence map›Paper›PMID 29603094›Full record

ArticleMolecular neurobiology2018

HERC1 Ubiquitin Ligase Is Required for Normal Axonal Myelination in the Peripheral Nervous System.

Sara Bachiller, María Angustias Roca-Ceballos, Irene García-Domínguez, Eva María Pérez-Villegas, David Martos-Carmona, Miguel Ángel Pérez-Castro, Luis Miguel Real, José Luis Rosa, Lucía Tabares, José Luis Venero and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Glia of the heart's nervous system.Nature reviews. Neuroscience · 2025
    Review
  2. Article
  3. Article
  4. Regulation of MAPK Signaling Pathways by the Large HERC Ubiquitin Ligases.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Sara BachillerDepartment of Physiology, Anatomy and Cellular Biology, University of Pablo de Olavide, Seville, Spain.
María Angustias Roca-CeballosDepartment of Biochemistry and Molecular Biology, School of Pharmacy, University of Seville, and Instituto de Biomedicina de Sevilla-Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Calle Profesor García González 2, 41012, Sevilla, Spain.
Irene García-DomínguezDepartment of Biochemistry and Molecular Biology, School of Pharmacy, University of Seville, and Instituto de Biomedicina de Sevilla-Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Calle Profesor García González 2, 41012, Sevilla, Spain.
Eva María Pérez-VillegasDepartment of Physiology, Anatomy and Cellular Biology, University of Pablo de Olavide, Seville, Spain.
David Martos-CarmonaDepartment of Physiology, Anatomy and Cellular Biology, University of Pablo de Olavide, Seville, Spain.
Miguel Ángel Pérez-CastroDepartment of Biochemistry and Molecular Biology, School of Pharmacy, University of Seville, and Instituto de Biomedicina de Sevilla-Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Calle Profesor García González 2, 41012, Sevilla, Spain.
Luis Miguel RealUnit of Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain.
José Luis RosaDepartament de Ciències Fisiològiques II, IDIBELL, Campus de Bellvitge, Universitat de Barcelona, L'Hospitalet de Llobregat, E-08907, Barcelona, Spain.
Lucía TabaresDepartment of Medical Physiology and Biophysics, School of Medicine, University of Seville, Seville, Spain.
José Luis VeneroDepartment of Biochemistry and Molecular Biology, School of Pharmacy, University of Seville, and Instituto de Biomedicina de Sevilla-Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Calle Profesor García González 2, 41012, Sevilla, Spain.
José Ángel ArmengolDepartment of Physiology, Anatomy and Cellular Biology, University of Pablo de Olavide, Seville, Spain.
Ángel Manuel CarriónDepartment of Physiology, Anatomy and Cellular Biology, University of Pablo de Olavide, Seville, Spain.
Rocío RuizDepartment of Physiology, Anatomy and Cellular Biology, University of Pablo de Olavide, Seville, Spain. rruizlaza@us.es.ORCID http://orcid.org/0000-0001-5142-9972
Instituto de Biomedicina de Sevilla · ESUniversidad Pablo de Olavide · ESHospital Universitario de Valme · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversidad de Sevilla · ES

Funding

Agencia de Innovación y Desarrollo de Andalucía BIO122Dirección General de Investigación Científica y Técnica BFU2011-27207Dirección General de Investigación Científica y Técnica BFU2015-64536-RSecretaría de Estado de Investigación, Desarrollo e Innovación JCI-2011_08888Secretaría de Estado de Investigación, Desarrollo e Innovación SAF2015-64171-RServicio Andaluz de Salud. Junta de Andalucía C-0009-2015Universidad de Sevilla V Plan Propio
6 · The paper itself

Abstract

A missense mutation in HERC1 provokes loss of cerebellar Purkinje cells, tremor, and unstable gait in tambaleante (tbl) mice. Recently, we have shown that before cerebellar degeneration takes place, the tbl mouse suffers from a reduction in the number of vesicles available for release at the neuromuscular junction (NMJ). The aim of the present work was to study to which extent the alteration in HERC1 may affect other cells in the nervous system and how this may influence the motor dysfunction observed in these mice. The functional analysis showed a consistent delay in the propagation of the action potential in mutant mice in comparison with control littermates. Morphological analyses of glial cells in motor axons revealed signs of compact myelin damage as tomacula and local hypermyelination foci. Moreover, we observed an alteration in non-myelinated terminal Schwann cells at the level of the NMJ. Additionally, we found a significant increment of phosphorylated Akt-2 in the sciatic nerve. Based on these findings, we propose a molecular model that could explain how mutated HERC1 in tbl mice affects the myelination process in the peripheral nervous system. Finally, since the myelin abnormalities found in tbl mice are histological hallmarks of neuropathic periphery diseases, tbl mutant mice could be considered as a new mouse model for this type of diseases.

Indexed as

AnimalsAxonsEvoked PotentialsMiceMice, Neurologic MutantsModels, BiologicalMutationMyelin Basic ProteinMyelin SheathNeuromuscular JunctionPeripheral Nervous SystemPhosphorylationPresynaptic TerminalsProto-Oncogene Proteins c-aktSchwann CellsSciatic NerveHERC1 protein, mouseMyelin Basic ProteinProto-Oncogene Proteins c-aktUbiquitin-Protein LigasesCharcot-Marie-toothInherited peripheral neuropathiesMyelinNeuromuscular junctionProteasome

Identifiers

PMID29603094
OpenAlexW2795016022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.